Konieczny J, Lenda T, Czarnecka A
Department of Neuropsychopharmacology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Krakow, Poland.
Department of Neuropsychopharmacology, Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Krakow, Poland.
Neuroscience. 2016 Jun 2;324:92-106. doi: 10.1016/j.neuroscience.2016.02.072. Epub 2016 Mar 7.
Since the discovery of the role of the ubiquitin-proteasome system (UPS) in the pathogenesis of Parkinson's disease, UPS inhibitors, such as lactacystin have been used to investigate the relationship between UPS impairment and degeneration of dopamine (DA) neurons. However, mostly long-term neurotoxic effects of lactacystin have been studied in animal models. Therefore, the aim of our study was to investigate behavioral and biochemical changes related to the DA system during the first week following unilateral intranigral injection of lactacystin to rats. We found that lactacystin produced early spontaneous contralateral rotations which were inhibited by combined administration of DA D1 and D2 receptor antagonists. Simultaneously, an increase in the extracellular level of DA and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanilic acid (HVA) was found in the ipsilateral striatum. In contrast, one week after lesion, when turning behavior was no longer visible, a decrease in the extracellular level of DA, DOPAC and HVA was demonstrated. It was accompanied by a substantial reduction in the tissue levels of DA and its metabolites in the lesioned substantia nigra and striatum. We concluded that unilateral intranigral administration of lactacystin produces an early increase in DA neurotransmission which precedes a decrease in the striatal and nigral tissue DA content. It is manifested by the appearance of spontaneous contralateral rotations and an elevation of the extracellular DA level in the ipsilateral striatum. Since similar behavior was previously observed after intranigral administration of rotenone and MPP(+) but not 6-hydroxydopamine (6-OHDA), it may indicate a common mechanism of action shared by these neurotoxins.
自从发现泛素-蛋白酶体系统(UPS)在帕金森病发病机制中的作用以来,诸如乳胞素之类的UPS抑制剂已被用于研究UPS功能障碍与多巴胺(DA)神经元变性之间的关系。然而,大多是在动物模型中研究了乳胞素的长期神经毒性作用。因此,我们研究的目的是在向大鼠单侧黑质内注射乳胞素后的第一周内,研究与DA系统相关的行为和生化变化。我们发现,乳胞素会引起早期自发性对侧旋转,而DA D1和D2受体拮抗剂联合给药可抑制这种旋转。同时,在同侧纹状体中发现DA及其代谢产物3,4-二羟基苯乙酸(DOPAC)和高香草酸(HVA)的细胞外水平升高。相反,损伤后一周,当不再出现旋转行为时,DA、DOPAC和HVA的细胞外水平降低。这伴随着损伤的黑质和纹状体中DA及其代谢产物的组织水平大幅降低。我们得出结论,单侧黑质内注射乳胞素会使DA神经传递早期增加,这先于纹状体和黑质组织中DA含量的降低。其表现为自发性对侧旋转的出现以及同侧纹状体中细胞外DA水平的升高。由于先前在黑质内注射鱼藤酮和MPP(+)后观察到了类似行为,但在注射6-羟基多巴胺(6-OHDA)后未观察到,这可能表明这些神经毒素具有共同的作用机制。